While Ozempic has gained popularity for its rapid weight loss side effect, the key word being rapid, it turns out there are some drawbacks to the fast results. Coined by dermatologist Dr. Paul Jarrod Frank, the phenomenon known as "Ozempic face” is discussed in the Medical News Today article.
The term refers to the facial side effects associated with semaglutide injections patients use to treat type 2 diabetes, but also for weight loss.
This weight loss can be particularly noticeable in the face due to the loss of fat cells that support skin structure and elasticity. Along with the loss of facial fat cells, the face also has reduced levels of elastin and collagen, which are essential for skin’s tightness and cell regrowth. The result is increased signs of aging such as wrinkles, sagging skin, lipodystrophy, which affects how the body accumulates and stores fat, and a hollowed-out appearance.
Other potential side effects of the drug not related to “Ozempic face” include gastrointestinal issues like nausea, vomiting, and diarrhea, as well as more severe conditions like thyroid cancer and pancreatitis.
While Ozempic isn't FDA-approved for weight management, its off-label use for this purpose has surged, contributing to a high demand despite limited supply issues in the United States. Treatment options for managing Ozempic's facial effects include lifestyle adjustments, hydration, and possibly dermatological fillers.
Note: The term “Ozempic face” refers to the effects from any medications in the same class as Ozempic including Wegovy and Mounjaro.
For more information on weight loss procedures and non-surgical options, contact Dr. Korman’s office: 310-5779-5540 or contact us today.
Comments